New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in South Korean Market

Informing the drug development and commercialization industry Cary, N.C. – June 27, 2013 – Industry Standard Research (ISR) released a new market research report this week entitled “South Korea: Clinical Development Country Profile.” The report provides insight into the clinical trial environment in South Korea, sponsor and service provider activities in the region, as well … Continued

ISR Reviews Report “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing”

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: ISR Reviews Report “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISR-Reviews-Report-Risk-based-Monitoring-Industry-/ArticleStandard/Article/detail/816364

ISR Reports: Significant Opportunity Remains for Optimizing Clinical Trials by Using Electronic Medical Records

Informing the drug development and commercialization industry Cary, N.C. – June 20, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “EMRs and Clinical Research: Current and Potential Impact.” This report provides the pharmaceutical industry and its service providers with novel insights into the current and future … Continued

ISR’s Liver Cancer Market Report Shows Opportunity for Innovative Sponsors

Informing the drug development and commercialization industry Cary, N.C. – June 6, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Liver Cancer: Disease and Pipeline Analysis,” providing the pharmaceutical industry with a therapeutic assessment, pipeline analysis, and unique insight into the current clinical trial environment for … Continued

ISR CUSTOMERS